Download PDF
Semin Respir Crit Care Med 2015; 36(04): 457-469
DOI: 10.1055/s-0035-1555607
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Epidemiology of Chronic Obstructive Pulmonary Disease: Prevalence, Morbidity, Mortality, and Risk Factors

Sharon R. Rosenberg
1   Asthma and COPD Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
Ravi Kalhan
1   Asthma and COPD Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
David M. Mannino
2   Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health, Lexington, Kentucky
› Author Affiliations
Further Information

Publication History

Publication Date:
03 August 2015 (online)

    Permissions and Reprints

Abstract

Chronic obstructive pulmonary disease (COPD) remains a common and important cause of morbidity and mortality both in the United States and globally. The increasing trends of COPD prevalence, morbidity, and mortality seen in the later part of last century have not continued in the United States. COPD prevalence, hospitalizations, and deaths have remained stable or are decreasing over the last decade. This is likely a function of the overall decreasing prevalence of tobacco use over the past 50 years, along with improved therapies for COPD. Future trends in COPD will probably be driven by factors in addition to tobacco use, such as longer survival in the population, other occupational and environmental exposures, and the increasing prevalence of asthma. Globally, factors such as air pollution and chronic respiratory infections, such as tuberculosis, will remain important predictors of future trends.

Keywords

chronic obstructive pulmonary disease - epidemiology - prevalence - morbidity - mortality
 

  • References

  • 1 Lozano R, Naghavi M, Foreman K , et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380 (9859) 2095-2128 [corrected in Lancet 2013;381(9867):628]
    CrossrefPubMedGoogle Scholar
  • 2 Vestbo J, Hurd SS, Agustí AG , et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187 (4) 347-365
    CrossrefPubMedGoogle Scholar
  • 3 Vestbo J, Agusti A, Wouters EF , et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Study Investigators. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med 2014; 189 (9) 1022-1030
    CrossrefPubMedGoogle Scholar
  • 4 Anthonisen NR, Connett JE, Kiley JP , et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272 (19) 1497-1505
    CrossrefPubMedGoogle Scholar
  • 5 Bednarek M, Gorecka D, Wielgomas J , et al. Smokers with airway obstruction are more likely to quit smoking. Thorax 2006; 61 (10) 869-873
    CrossrefPubMedGoogle Scholar
  • 6 Ulrik CS, Løkke A, Dahl R , et al; TOP study group. Early detection of COPD in general practice. Int J Chron Obstruct Pulmon Dis 2011; 6: 123-127
    PubMedGoogle Scholar
  • 7 Croxton TL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med 2006; 174 (4) 373-378
    CrossrefPubMedGoogle Scholar
  • 8 Celli B, Cross S, Grossman R , et al. Improving the care of COPD patients - suggested action points by the COPD exacerbations taskforce for reducing the burden of exacerbations of COPD. Prim Care Respir J 2006; 15 (3) 139-142
    CrossrefPubMedGoogle Scholar
  • 9 Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration 2005; 72 (5) 471-479
    CrossrefPubMedGoogle Scholar
  • 10 Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22 (2) 268-273
    CrossrefPubMedGoogle Scholar
  • 11 Hnizdo E, Glindmeyer HW, Petsonk EL, Enright P, Buist AS. Case definitions for chronic obstructive pulmonary disease. COPD 2006; 3 (2) 95-100
    CrossrefPubMedGoogle Scholar
  • 12 Lindberg A, Bjerg A, Rönmark E, Larsson LG, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006; 100 (2) 264-272 [corrected in Respir Med 2007;101(12):2569]
    CrossrefPubMedGoogle Scholar
  • 13 Lundbäck B, Lindberg A, Lindström M , et al; Obstructive Lung Disease in Northern Sweden Studies. Not 15 but 50% of smokers develop COPD?—Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97 (2) 115-122
    CrossrefPubMedGoogle Scholar
  • 14 Buist AS, McBurnie MA, Vollmer WM , et al; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370 (9589) 741-750
    CrossrefPubMedGoogle Scholar
  • 15 Menezes AM, Perez-Padilla R, Jardim JR , et al; PLATINO Team. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366 (9500) 1875-1881
    CrossrefPubMedGoogle Scholar
  • 16 Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370 (9589) 765-773
    CrossrefPubMedGoogle Scholar
  • 17 Burney P, Jithoo A, Kato B , et al; Burden of Obstructive Lung Disease (BOLD) Study. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty—a BOLD analysis. Thorax 2014; 69 (5) 465-473
    CrossrefPubMedGoogle Scholar
  • 18 Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 2000; 117 (2, Suppl): 1S-4S
    CrossrefPubMedGoogle Scholar
  • 19 Pauwels R. COPD: the scope of the problem in Europe. Chest 2000; 117 (5) (Suppl. 02) 332S-335S
    CrossrefPubMedGoogle Scholar
  • 20 Petty TL. Scope of the COPD problem in North America: early studies of prevalence and NHANES III data: basis for early identification and intervention. Chest 2000; 117 (5) (Suppl. 02) 326S-331S
    CrossrefPubMedGoogle Scholar
  • 21 Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance—United States, 1999-2011. Chest 2013; 144 (1) 284-305
    CrossrefPubMedGoogle Scholar
  • 22 Vasankari TM, Impivaara O, Heliövaara M , et al. No increase in the prevalence of COPD in two decades. Eur Respir J 2010; 36 (4) 766-773
    CrossrefPubMedGoogle Scholar
  • 23 Soriano JB, Ancochea J, Miravitlles M , et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur Respir J 2010; 36 (4) 758-765
    CrossrefPubMedGoogle Scholar
  • 24 Gershon AS, Wang C, Wilton AS, Raut R, To T. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med 2010; 170 (6) 560-565
    CrossrefPubMedGoogle Scholar
  • 25 Kojima S, Sakakibara H, Motani S , et al. Incidence of chronic obstructive pulmonary disease, and the relationship between age and smoking in a Japanese population. J Epidemiol 2007; 17 (2) 54-60
    CrossrefPubMedGoogle Scholar
  • 26 de Marco R, Accordini S, Cerveri I , et al; European Community Respiratory Health Survey Study Group. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004; 59 (2) 120-125
    CrossrefPubMedGoogle Scholar
  • 27 Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—United States, 1971-2000. MMWR Surveill Summ 2002; 51 (6) 1-16
    PubMedGoogle Scholar
  • 28 Tan WC, Seale P, Ip M , et al. Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific. Respirology 2009; 14 (1) 90-97
    CrossrefPubMedGoogle Scholar
  • 29 Chronic Obstructive Pulmonary Disease. 2014. Available at: http://www.cdc.gov/copd/data.htm . Accessed September 26, 2014
    PubMedGoogle Scholar
  • 30 Centers for Disease Control and Prevention (CDC). Chronic obstructive pulmonary disease among adults—United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61 (46) 938-943
    PubMedGoogle Scholar
  • 31 Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest 2013; 143 (5) 1395-1406
    CrossrefPubMedGoogle Scholar
  • 32 Chapman KR, Mannino DM, Soriano JB , et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27 (1) 188-207
    CrossrefPubMedGoogle Scholar
  • 33 Ford ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. Chest 2015; 147 (1) 31-45
    CrossrefPubMedGoogle Scholar
  • 34 Rabe KF, Hurd S, Anzueto A , et al; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176 (6) 532-555
    CrossrefPubMedGoogle Scholar
  • 35 Aït-Khaled N, Enarson D, Bousquet J. Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bull World Health Organ 2001; 79 (10) 971-979
    PubMedGoogle Scholar
  • 36 Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J. Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature. COPD 2006; 3 (4) 211-218
    CrossrefPubMedGoogle Scholar
  • 37 Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005; 128 (4) 2005-2011
    CrossrefPubMedGoogle Scholar
  • 38 Anthonisen NR, Connett JE, Enright PL, Manfreda J ; Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166 (3) 333-339
    CrossrefPubMedGoogle Scholar
  • 39 Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22 (5) 809-814
    CrossrefPubMedGoogle Scholar
  • 40 Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med 2003; 163 (12) 1475-1480
    CrossrefPubMedGoogle Scholar
  • 41 Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32 (4) 962-969
    CrossrefPubMedGoogle Scholar
  • 42 Jørgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 2007; 101 (1) 177-185
    CrossrefPubMedGoogle Scholar
  • 43 Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007; 29 (5) 923-929
    CrossrefPubMedGoogle Scholar
  • 44 Hill K, Geist R, Goldstein RS, Lacasse Y. Anxiety and depression in end-stage COPD. Eur Respir J 2008; 31 (3) 667-677
    CrossrefPubMedGoogle Scholar
  • 45 Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 2005; 26 (4) 703-719
    CrossrefPubMedGoogle Scholar
  • 46 Celli BR, Cote CG, Marin JM , et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350 (10) 1005-1012
    CrossrefPubMedGoogle Scholar
  • 47 Crisafulli E, Costi S, Luppi F , et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax 2008; 63 (6) 487-492
    CrossrefPubMedGoogle Scholar
  • 48 van Manen JG, Bindels PJ, Dekker FW , et al. The influence of COPD on health-related quality of life independent of the influence of comorbidity. J Clin Epidemiol 2003; 56 (12) 1177-1184
    CrossrefPubMedGoogle Scholar
  • 49 Antonelli Incalzi R, Fuso L, De Rosa M , et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10 (12) 2794-2800
    CrossrefPubMedGoogle Scholar
  • 50 Terzano C, Conti V, Di Stefano F , et al. Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung 2010; 188 (4) 321-329
    CrossrefPubMedGoogle Scholar
  • 51 van Manen JG, Bindels PJ, IJzermans CJ, van der Zee JS, Bottema BJ, Schadé E. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001; 54 (3) 287-293
    CrossrefPubMedGoogle Scholar
  • 52 Berry CE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD 2010; 7 (5) 375-382
    CrossrefPubMedGoogle Scholar
  • 53 McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA ; TORCH Clinical Endpoint Committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62 (5) 411-415
    CrossrefPubMedGoogle Scholar
  • 54 Camp PG, Chaudhry M, Platt H , et al. The sex factor: epidemiology and management of chronic obstructive pulmonary disease in British Columbia. Can Respir J 2008; 15 (8) 417-422
    PubMedGoogle Scholar
  • 55 Nie JX, Wang L, Upshur RE. Mortality of elderly patients in Ontario after hospital admission for chronic obstructive pulmonary disease. Can Respir J 2007; 14 (8) 485-489
    PubMedGoogle Scholar
  • 56 Lindberg A, Lundbäck B. The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality. Clin Respir J 2008; 2 (Suppl. 01) 64-71
    CrossrefPubMedGoogle Scholar
  • 57 Janssen F, Kunst AE ; Netherlands Epidemiology and Demography Compression of Morbidity research group. Cohort patterns in mortality trends among the elderly in seven European countries, 1950-99. Int J Epidemiol 2005; 34 (5) 1149-1159
    CrossrefPubMedGoogle Scholar
  • 58 Wilson DH, Tucker G, Frith P, Appleton S, Ruffin RE, Adams RJ. Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia, 1993-2003. Med J Aust 2007; 186 (8) 408-411
    PubMedGoogle Scholar
  • 59 Janssen F, Nusselder WJ, Looman CW, Mackenbach JP, Kunst AE. Stagnation in mortality decline among elders in the Netherlands. Gerontologist 2003; 43 (5) 722-734
    CrossrefPubMedGoogle Scholar
  • 60 Berend N. Epidemiological survey of chronic obstructive pulmonary disease and alpha-1-antitrypsin deficiency in Australia. Respirology 2001; 6 (Suppl): S21-S25
    CrossrefPubMedGoogle Scholar
  • 61 Puhan MA, Garcia-Aymerich J, Frey M , et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374 (9691) 704-711
    CrossrefPubMedGoogle Scholar
  • 62 Jones RC, Donaldson GC, Chavannes NH , et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med 2009; 180 (12) 1189-1195
    CrossrefPubMedGoogle Scholar
  • 63 Divo M, Cote C, de Torres JP , et al; BODE Collaborative Group. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186 (2) 155-161
    CrossrefPubMedGoogle Scholar
  • 64 Lange P, Marott JL, Vestbo J , et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012; 186 (10) 975-981
    CrossrefPubMedGoogle Scholar
  • 65 WHO. WHO Report on the Global Tobacco Epidemic: 2011. Geneva: World Health Organization; 2011
    Google Scholar
  • 66 Giovino GA, Mirza SA, Samet JM , et al; GATS Collaborative Group. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012; 380 (9842) 668-679
    CrossrefPubMedGoogle Scholar
  • 67 Foreman MG, Zhang L, Murphy J , et al; COPDGene Investigators. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med 2011; 184 (4) 414-420
    CrossrefPubMedGoogle Scholar
  • 68 Agustí A, MacNee W, Donaldson K, Cosio M. Hypothesis: does COPD have an autoimmune component?. Thorax 2003; 58 (10) 832-834
    CrossrefPubMedGoogle Scholar
  • 69 Marsh S, Aldington S, Shirtcliffe P, Weatherall M, Beasley R. Smoking and COPD: What really are the risks?. Eur Respir J 2006; 28 (4) 883-884
    CrossrefPubMedGoogle Scholar
  • 70 Lopez AD, Begg S, Bos E. Demographic and Epidemiological Characteristics of Major Regions, 1990–2001. In: Lopez AD, Mathers CD, Ezzati M, , et al., editors. Global Burden of Disease and Risk Factors. Washington (DC): World Bank; 2006. . Chapter 2. Available from: http://www.ncbi.nlm.nih.gov/books/NBK11807/
    CrossrefGoogle Scholar
  • 71 Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD, Lin RB, Murray CJ ; Comparative Risk Assessment Collaborating Group. Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med 2004; 1 (1) e27
    CrossrefPubMedGoogle Scholar
  • 72 Gilliland FD, Li YF, Dubeau L , et al. Effects of glutathione S-transferase M1, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 2002; 166 (4) 457-463
    CrossrefPubMedGoogle Scholar
  • 73 Thun MJ, Carter BD, Feskanich D , et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013; 368 (4) 351-364
    CrossrefPubMedGoogle Scholar
  • 74 Taylor Jr DH, Hasselblad V, Henley SJ, Thun MJ, Sloan FA. Benefits of smoking cessation for longevity. Am J Public Health 2002; 92 (6) 990-996
    CrossrefPubMedGoogle Scholar
  • 75 Najafzadeh M, Marra CA, Lynd LD , et al. Future impact of various interventions on the burden of COPD in Canada: a dynamic population model. PLoS ONE 2012; 7 (10) e46746
    CrossrefPubMedGoogle Scholar
  • 76 Rutgers SR, Postma DS, ten Hacken NH , et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000; 55 (1) 12-18
    CrossrefPubMedGoogle Scholar
  • 77 Xu X, Dockery DW, Ware JH, Speizer FE, Ferris Jr BG. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis 1992; 146 (5, Pt 1) 1345-1348
    CrossrefPubMedGoogle Scholar
  • 78 Simmons MS, Connett JE, Nides MA , et al. Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study. Eur Respir J 2005; 25 (6) 1011-1017
    CrossrefPubMedGoogle Scholar
  • 79 Sherrill DL, Holberg CJ, Enright PL, Lebowitz MD, Burrows B. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function. Am J Respir Crit Care Med 1994; 149 (3, Pt 1) 591-597
    CrossrefPubMedGoogle Scholar
  • 80 Scanlon PD, Connett JE, Waller LA , et al; Lung Health Study Research Group. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161 (2, Pt 1) 381-390
    CrossrefPubMedGoogle Scholar
  • 81 Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE ; Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142 (4) 233-239
    CrossrefPubMedGoogle Scholar
  • 82 Celli BR, Halbert RJ, Nordyke RJ, Schau B. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med 2005; 118 (12) 1364-1372
    CrossrefPubMedGoogle Scholar
  • 83 Lamprecht B, Schirnhofer L, Kaiser B, Buist S, Studnicka M. Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study. Respir Med 2008; 102 (12) 1833-1838
    CrossrefPubMedGoogle Scholar
  • 84 Behrendt CE. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest 2005; 128 (3) 1239-1244
    CrossrefPubMedGoogle Scholar
  • 85 Bridevaux PO, Probst-Hensch NM, Schindler C , et al. Prevalence of airflow obstruction in smokers and never-smokers in Switzerland. Eur Respir J 2010; 36 (6) 1259-1269
    CrossrefPubMedGoogle Scholar
  • 86 Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374 (9691) 733-743
    CrossrefPubMedGoogle Scholar
  • 87 Lamprecht B, McBurnie MA, Vollmer WM , et al; BOLD Collaborative Research Group. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest 2011; 139 (4) 752-763
    CrossrefPubMedGoogle Scholar
  • 88 Zhou Y, Wang C, Yao W , et al. COPD in Chinese nonsmokers. Eur Respir J 2009; 33 (3) 509-518
    CrossrefPubMedGoogle Scholar
  • 89 Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126 (1) 59-65
    CrossrefPubMedGoogle Scholar
  • 90 Xu X, Rijcken B, Schouten JP, Weiss ST. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997; 350 (9089) 1431-1434
    CrossrefPubMedGoogle Scholar
  • 91 American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152 (5, Pt 2) S77-S121
    PubMedGoogle Scholar
  • 92 Vonk JM, Jongepier H, Panhuysen CI, Schouten JP, Bleecker ER, Postma DS. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003; 58 (4) 322-327
    CrossrefPubMedGoogle Scholar
  • 93 Hudon C, Turcotte H, Laviolette M, Carrier G, Boulet LP. Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction. Annals of Allergy, Asthma Immunology. 1997; 78 (2) 195-202
    PubMedGoogle Scholar
  • 94 Reed CE. The natural history of asthma in adults: the problem of irreversibility. J Allergy Clin Immunol 1999; 103 (4) 539-547
    CrossrefPubMedGoogle Scholar
  • 95 Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J 1999; 14 (4) 892-896
    CrossrefPubMedGoogle Scholar
  • 96 Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339 (17) 1194-1200
    CrossrefPubMedGoogle Scholar
  • 97 Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987; 70 (3) 171-179
    PubMedGoogle Scholar
  • 98 Sherrill D, Guerra S, Bobadilla A, Barbee R. The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics. Eur Respir J 2003; 21 (1) 95-100
    CrossrefPubMedGoogle Scholar
  • 99 Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994; 150 (3) 629-634
    CrossrefPubMedGoogle Scholar
  • 100 Cassino C, Berger KI, Goldring RM , et al. Duration of asthma and physiologic outcomes in elderly nonsmokers. Am J Respir Crit Care Med 2000; 162 (4, Pt 1) 1423-1428
    CrossrefPubMedGoogle Scholar
  • 101 Connolly CK, Chan NS, Prescott RJ. The relationship between age and duration of asthma and the presence of persistent obstruction in asthma. Postgrad Med J 1988; 64 (752) 422-425
    CrossrefPubMedGoogle Scholar
  • 102 Balmes J, Becklake M, Blanc P , et al; Environmental and Occupational Health Assembly, American Thoracic Society. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003; 167 (5) 787-797
    CrossrefPubMedGoogle Scholar
  • 103 Trupin L, Earnest G, San Pedro M , et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003; 22 (3) 462-469
    CrossrefPubMedGoogle Scholar
  • 104 Bergdahl IA, Torén K, Eriksson K , et al. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur Respir J 2004; 23 (3) 402-406
    CrossrefPubMedGoogle Scholar
  • 105 Hnizdo E, Sullivan PA, Bang KM, Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2002; 156 (8) 738-746
    CrossrefPubMedGoogle Scholar
  • 106 Harber P, Tashkin DP, Simmons M, Crawford L, Hnizdo E, Connett J ; Lung Health Study Group. Effect of occupational exposures on decline of lung function in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176 (10) 994-1000
    CrossrefPubMedGoogle Scholar
  • 107 Blanc PD, Iribarren C, Trupin L , et al. Occupational exposures and the risk of COPD: dusty trades revisited. Thorax 2009; 64 (1) 6-12
    PubMedGoogle Scholar
  • 108 Blanc PD, Menezes AM, Plana E , et al. Occupational exposures and COPD: an ecological analysis of international data. Eur Respir J 2009; 33 (2) 298-304
    CrossrefPubMedGoogle Scholar
  • 109 Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ 2000; 78 (9) 1078-1092
    PubMedGoogle Scholar
  • 110 Kurmi OP, Semple S, Simkhada P, Smith WC, Ayres JG. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax 2010; 65 (3) 221-228
    CrossrefPubMedGoogle Scholar
  • 111 Orozco-Levi M, Garcia-Aymerich J, Villar J, Ramírez-Sarmiento A, Antó JM, Gea J. Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur Respir J 2006; 27 (3) 542-546
    CrossrefPubMedGoogle Scholar
  • 112 Osman LM, Douglas JG, Garden C , et al. Indoor air quality in homes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176 (5) 465-472
    CrossrefPubMedGoogle Scholar
  • 113 Hunt A, Abraham JL, Judson B, Berry CL. Toxicologic and epidemiologic clues from the characterization of the 1952 London smog fine particulate matter in archival autopsy lung tissues. Environ Health Perspect 2003; 111 (9) 1209-1214
    CrossrefPubMedGoogle Scholar
  • 114 Sunyer J. Urban air pollution and chronic obstructive pulmonary disease: a review. Eur Respir J 2001; 17 (5) 1024-1033
    CrossrefPubMedGoogle Scholar
  • 115 Holguin F, Flores S, Ross Z , et al. Traffic-related exposures, airway function, inflammation, and respiratory symptoms in children. Am J Respir Crit Care Med 2007; 176 (12) 1236-1242
    CrossrefPubMedGoogle Scholar
  • 116 Nicolai T, Carr D, Weiland SK , et al. Urban traffic and pollutant exposure related to respiratory outcomes and atopy in a large sample of children. Eur Respir J 2003; 21 (6) 956-963
    CrossrefPubMedGoogle Scholar
  • 117 Janssen NA, Brunekreef B, van Vliet P , et al. The relationship between air pollution from heavy traffic and allergic sensitization, bronchial hyperresponsiveness, and respiratory symptoms in Dutch schoolchildren. Environ Health Perspect 2003; 111 (12) 1512-1518
    CrossrefPubMedGoogle Scholar
  • 118 Hogervorst JG, de Kok TM, Briedé JJ, Wesseling G, Kleinjans JC, van Schayck CP. Relationship between radical generation by urban ambient particulate matter and pulmonary function of school children. J Toxicol Environ Health A 2006; 69 (3-4) 245-262
    CrossrefPubMedGoogle Scholar
  • 119 Tager IB, Balmes J, Lurmann F, Ngo L, Alcorn S, Künzli N. Chronic exposure to ambient ozone and lung function in young adults. Epidemiology 2005; 16 (6) 751-759
    CrossrefPubMedGoogle Scholar
  • 120 Kulkarni N, Pierse N, Rushton L, Grigg J. Carbon in airway macrophages and lung function in children. N Engl J Med 2006; 355 (1) 21-30
    CrossrefPubMedGoogle Scholar
  • 121 Frye C, Hoelscher B, Cyrys J, Wjst M, Wichmann HE, Heinrich J. Association of lung function with declining ambient air pollution. Environ Health Perspect 2003; 111 (3) 383-387
    CrossrefPubMedGoogle Scholar
  • 122 Sugiri D, Ranft U, Schikowski T, Krämer U. The influence of large-scale airborne particle decline and traffic-related exposure on children's lung function. Environ Health Perspect 2006; 114 (2) 282-288
    CrossrefPubMedGoogle Scholar
  • 123 Avol EL, Gauderman WJ, Tan SM, London SJ, Peters JM. Respiratory effects of relocating to areas of differing air pollution levels. Am J Respir Crit Care Med 2001; 164 (11) 2067-2072
    CrossrefPubMedGoogle Scholar
  • 124 Schikowski T, Sugiri D, Ranft U , et al. Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir Res 2005; 6: 152
    CrossrefPubMedGoogle Scholar
  • 125 Ackermann-Liebrich U, Leuenberger P, Schwartz J , et al; Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) Team. Lung function and long term exposure to air pollutants in Switzerland. Am J Respir Crit Care Med 1997; 155 (1) 122-129
    CrossrefPubMedGoogle Scholar
  • 126 Forbes LJ, Kapetanakis V, Rudnicka AR , et al. Chronic exposure to outdoor air pollution and lung function in adults. Thorax 2009; 64 (8) 657-663
    CrossrefPubMedGoogle Scholar
  • 127 Chen Y, Horne SL, Dosman JA. Increased susceptibility to lung dysfunction in female smokers. Am Rev Respir Dis 1991; 143 (6) 1224-1230
    CrossrefPubMedGoogle Scholar
  • 128 Gan WQ, Man SF, Postma DS, Camp P, Sin DD. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res 2006; 7: 52
    CrossrefPubMedGoogle Scholar
  • 129 Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Sex differences in lung vulnerability to tobacco smoking. Eur Respir J 2003; 21 (6) 1017-1023
    CrossrefPubMedGoogle Scholar
  • 130 Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997; 10 (4) 822-827
    PubMedGoogle Scholar
  • 131 Xu X, Weiss ST, Rijcken B, Schouten JP. Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. Eur Respir J 1994; 7 (6) 1056-1061
    PubMedGoogle Scholar
  • 132 Sørheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men?. Thorax 2010; 65 (6) 480-485
    CrossrefPubMedGoogle Scholar
  • 133 Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001; 119 (6) 1691-1695
    CrossrefPubMedGoogle Scholar
  • 134 Miravitlles M, de la Roza C, Naberan K , et al. [Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care]. Arch Bronconeumol 2006; 42 (1) 3-8
    PubMedGoogle Scholar
  • 135 Kesten S, Chapman KR. Physician perceptions and management of COPD. Chest 1993; 104 (1) 254-258
    CrossrefPubMedGoogle Scholar
  • 136 Watson L, Vestbo J, Postma DS , et al. Gender differences in the management and experience of chronic obstructive pulmonary disease. Respir Med 2004; 98 (12) 1207-1213
    CrossrefPubMedGoogle Scholar
  • 137 Døssing M, Khan J, al-Rabiah F. Risk factors for chronic obstructive lung disease in Saudi Arabia. Respir Med 1994; 88 (7) 519-522
    CrossrefPubMedGoogle Scholar
  • 138 Dennis RJ, Maldonado D, Norman S, Baena E, Martinez G. Woodsmoke exposure and risk for obstructive airways disease among women. Chest 1996; 109 (1) 115-119
    CrossrefPubMedGoogle Scholar
  • 139 Pérez-Padilla R, Regalado J, Vedal S , et al. Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study. Am J Respir Crit Care Med 1996; 154 (3, Pt 1) 701-706
    CrossrefPubMedGoogle Scholar
  • 140 Ekici A, Ekici M, Kurtipek E , et al. Obstructive airway diseases in women exposed to biomass smoke. Environ Res 2005; 99 (1) 93-98
    CrossrefPubMedGoogle Scholar
  • 141 Peabody JW, Riddell TJ, Smith KR , et al. Indoor air pollution in rural China: cooking fuels, stoves, and health status. Arch Environ Occup Health 2005; 60 (2) 86-95
    CrossrefPubMedGoogle Scholar
  • 142 Liu S, Zhou Y, Wang X , et al. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax 2007; 62 (10) 889-897
    CrossrefPubMedGoogle Scholar
  • 143 Romieu I, Riojas-Rodríguez H, Marrón-Mares AT, Schilmann A, Perez-Padilla R, Masera O. Improved biomass stove intervention in rural Mexico: impact on the respiratory health of women. Am J Respir Crit Care Med 2009; 180 (7) 649-656
    CrossrefPubMedGoogle Scholar
  • 144 Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet 2005; 365 (9478) 2225-2236
    CrossrefPubMedGoogle Scholar
  • 145 American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168 (7) 818-900
    CrossrefPubMedGoogle Scholar
  • 146 Seersholm N, Kok-Jensen A, Dirksen A. Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases. Thorax 1994; 49 (7) 695-698
    CrossrefPubMedGoogle Scholar
  • 147 Piitulainen E, Tornling G, Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ). Thorax 1997; 52 (3) 244-248
    CrossrefPubMedGoogle Scholar
  • 148 Ingebrigtsen T, Thomsen SF, Vestbo J , et al. Genetic influences on chronic obstructive pulmonary disease—a twin study. Respir Med 2010; 104 (12) 1890-1895
    CrossrefPubMedGoogle Scholar
  • 149 Lee JH, Cho MH, Hersh CP , et al; COPDGene and ECLIPSE Investigators. Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease. Respir Res 2014; 15: 113
    CrossrefPubMedGoogle Scholar
  • 150 Hooper R, Burney P, Vollmer WM , et al. Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project. Eur Respir J 2012; 39 (6) 1343-1353
    CrossrefPubMedGoogle Scholar
  • 151 Allwood BW, Myer L, Bateman ED. A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults. Respiration 2013; 86 (1) 76-85
    CrossrefPubMedGoogle Scholar
  • 152 Andréjak C, Nielsen R, Thomsen VO, Duhaut P, Sørensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax 2013; 68 (3) 256-262
    CrossrefPubMedGoogle Scholar
  • 153 Kim JH, Park JS, Kim KH, Jeong HC, Kim EK, Lee JH. Inhaled corticosteroid is associated with an increased risk of TB in patients with COPD. Chest 2013; 143 (4) 1018-1024
    CrossrefPubMedGoogle Scholar
  • 154 Lee CH, Lee MC, Lin HH , et al. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS ONE 2012; 7 (5) e37978
    CrossrefPubMedGoogle Scholar
  • 155 Carraro S, Filippone M, Da Dalt L , et al. Bronchopulmonary dysplasia: the earliest and perhaps the longest lasting obstructive lung disease in humans. Early Hum Dev 2013; 89 (Suppl. 03) S3-S5
    PubMedGoogle Scholar
  • 156 Vollsæter M, Røksund OD, Eide GE, Markestad T, Halvorsen T. Lung function after preterm birth: development from mid-childhood to adulthood. Thorax 2013; 68 (8) 767-776
    CrossrefPubMedGoogle Scholar
  • 157 Filippone M, Carraro S, Baraldi E. From BPD to COPD? The hypothesis is intriguing but we lack lung pathology data in humans. Eur Respir J 2010; 35 (6) 1419-1420 , author reply 1420
    CrossrefPubMedGoogle Scholar
  • 158 Madeddu G, Fois AG, Calia GM , et al. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era?. Infection 2013; 41 (2) 347-353
    CrossrefPubMedGoogle Scholar
  • 159 Raynaud C, Roche N, Chouaid C. Interactions between HIV infection and chronic obstructive pulmonary disease: clinical and epidemiological aspects. Respir Res 2011; 12: 117
    CrossrefPubMedGoogle Scholar
  • 160 Sze MA, Hogg JC, Sin DD. Bacterial microbiome of lungs in COPD. Int J Chron Obstruct Pulmon Dis 2014; 9: 229-238
    PubMedGoogle Scholar
  • 161 Sethi S. Chronic obstructive pulmonary disease and infection. Disruption of the microbiome?. Ann Am Thorac Soc 2014; 11 (Suppl. 01) S43-S47
    PubMedGoogle Scholar
  • 162 Garrett BE, Dube SR, Trosclair A, Caraballo RS, Pechacek TF ; Centers for Disease Control and Prevention (CDC). Cigarette smoking—United States, 1965-2008. MMWR Surveill Summ 2011; 60 (Suppl): 109-113
    PubMedGoogle Scholar